The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-5-((7-fluoro-6-methoxy-1-oxoisoindolin-2-yl)methyl)-5-(5-(3-oxopiperazin-1-yl)furo[3,2-b]pyridin-2-yl)imidazolidine-2,4-dione ID: ALA4095929
PubChem CID: 46199503
Max Phase: Preclinical
Molecular Formula: C24H21FN6O6
Molecular Weight: 508.47
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc2c(c1F)C(=O)N(C[C@@]1(c3cc4nc(N5CCNC(=O)C5)ccc4o3)NC(=O)NC1=O)C2
Standard InChI: InChI=1S/C24H21FN6O6/c1-36-15-3-2-12-9-31(21(33)19(12)20(15)25)11-24(22(34)28-23(35)29-24)16-8-13-14(37-16)4-5-17(27-13)30-7-6-26-18(32)10-30/h2-5,8H,6-7,9-11H2,1H3,(H,26,32)(H2,28,29,34,35)/t24-/m0/s1
Standard InChI Key: WSTMGDNKJKKYFC-DEOSSOPVSA-N
Molfile:
RDKit 2D
37 42 0 0 0 0 0 0 0 0999 V2000
9.3849 -16.1570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.9766 -16.8737 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8015 -16.8690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8972 -17.6614 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.7223 -17.6614 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3098 -16.3903 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6445 -16.8771 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2181 -17.5813 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.8918 -18.3344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0442 -17.6603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.5916 -17.0429 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.2204 -18.4663 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5100 -18.8812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.5150 -19.7021 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2298 -20.1090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9409 -19.6891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9325 -18.8696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6597 -20.0944 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6680 -20.9195 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2079 -18.3285 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.8597 -16.6224 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.2043 -16.0614 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.0446 -15.4007 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6489 -14.8431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3683 -15.2533 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0810 -14.8353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0755 -14.0076 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3514 -13.5993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6416 -14.0196 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3426 -12.7743 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0553 -12.3592 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0485 -11.5377 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3313 -11.1288 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
9.6194 -11.5478 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6245 -12.3755 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7603 -11.1202 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.6431 -18.4505 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 1
3 2 1 0
4 5 1 0
5 2 1 0
2 6 1 0
6 7 1 0
7 4 1 0
3 8 1 0
8 9 1 0
9 13 1 0
12 10 1 0
10 8 1 0
10 11 2 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
16 18 1 0
18 19 1 0
5 20 2 0
7 21 2 0
1 22 1 0
22 25 1 0
24 23 1 0
23 1 2 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 29 2 0
29 24 1 0
28 30 1 0
30 31 1 0
30 35 1 0
31 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
32 36 2 0
17 37 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 508.47Molecular Weight (Monoisotopic): 508.1507AlogP: 0.60#Rotatable Bonds: 5Polar Surface Area: 146.11Molecular Species: NEUTRALHBA: 8HBD: 3#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 8.63CX Basic pKa: 3.91CX LogP: 0.07CX LogD: 0.05Aromatic Rings: 3Heavy Atoms: 37QED Weighted: 0.43Np Likeness Score: -0.82
References 1. Tong L, Kim SH, Rosner K, Yu W, Shankar BB, Chen L, Li D, Dai C, Girijavallabhan V, Popovici-Muller J, Yang L, Zhou G, Kosinski A, Siddiqui MA, Shih NY, Guo Z, Orth P, Chen S, Lundell D, Niu X, Umland S, Kozlowski JA.. (2017) Fused bi-heteroaryl substituted hydantoin compounds as TACE inhibitors., 27 (14): [PMID:28558971 ] [10.1016/j.bmcl.2017.05.062 ]